Evidence map›Paper›PMID 36109670›Full record

ArticleNature cell biology2022

Single-cell atlas of human liver development reveals pathways directing hepatic cell fates.

Brandon T Wesley, Alexander D B Ross, Daniele Muraro, Zhichao Miao, Sarah Saxton, Rute A Tomaz, Carola M Morell, Katherine Ridley, Ekaterini D Zacharis, Sandra Petrus-Reurer and 22 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 8 institutions in 3 countries.

Brandon T Wesley *Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0530-329X
Alexander D B Ross *Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Daniele MuraroWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Zhichao MiaoWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-5777-9815
Sarah SaxtonDepartments of Bioengineering and Pathology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-3901-4843
Rute A TomazWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Carola M MorellWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Katherine RidleyWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Ekaterini D ZacharisWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Sandra Petrus-ReurerDepartment of Surgery, University of Cambridge, Cambridge, UK.
Judith KraiczyDepartment of Paediatrics, University of Cambridge, Cambridge, UK.
Krishnaa T MahbubaniDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1327-2334
Stephanie BrownWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Jose Garcia-BernardoWellcome Sanger Institute, Hinxton, UK.
Clara AlsinetWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-7779-0667
Daniel GaffneyWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-1529-1862
Dave HorsfallDigital Institute, Newcastle University, Newcastle upon Tyne, UK.
Olivia C TysoeWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Rachel A BottingBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-9595-4605
Emily StephensonBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Dorin-Mirel PopescuBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Sonya MacParlandUniversity of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-8036-1425
Gary BaderUniversity of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-0185-8861
Ian D McGilvrayMulti-Organ Transplant Program, Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
Daniel OrtmannWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Fotios SampaziotisWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-0812-7586
Kourosh Saeb-ParsyDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0633-3696
Muzlifah HaniffaWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-3927-2084
Kelly R StevensDepartments of Bioengineering and Pathology, University of Washington, Seattle, WA, USA.
Matthias ZilbauerWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Sarah A Teichmann *Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-6294-6366
Ludovic Vallier *Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. lv225@cam.ac.uk.ORCID 0000-0002-3848-2602
Wellcome/MRC Cambridge Stem Cell Institute · GBUniversity of Cambridge · GBNewcastle University · GBWellcome Sanger Institute · GBUniversity of Toronto · CAUniversity of Washington · USEuropean Bioinformatics Institute · GBToronto General Hospital · CA

Funding

Department of HealthEuropean Research Council 693878European Research Council 741707Medical Research Council G0701448National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/N001540/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/R001987/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/T2T0419Wellcome Trust 206194Wellcome Trust WT206194
6 · The paper itself

Abstract

The liver has been studied extensively due to the broad number of diseases affecting its vital functions. However, therapeutic advances have been hampered by the lack of knowledge concerning human hepatic development. Here, we addressed this limitation by describing the developmental trajectories of different cell types that make up the human liver at single-cell resolution. These transcriptomic analyses revealed that sequential cell-to-cell interactions direct functional maturation of hepatocytes, with non-parenchymal cells playing essential roles during organogenesis. We utilized this information to derive bipotential hepatoblast organoids and then exploited this model system to validate the importance of signalling pathways in hepatocyte and cholangiocyte specification. Further insights into hepatic maturation also enabled the identification of stage-specific transcription factors to improve the functionality of hepatocyte-like cells generated from human pluripotent stem cells. Thus, our study establishes a platform to investigate the basic mechanisms directing human liver development and to produce cell types for clinical applications.

Indexed as

HepatocytesLiverCell DifferentiationHumansOrganoidsTranscription FactorsTranscription Factors

Identifiers

PMID36109670
PMCPMC7617064
OpenAlexW4295950911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.